Neumentum Enters into Global Licensing Agreement for a Novel Class of Investigational Pain Treatments

Agreement significantly expands Neumentum’s pipeline of investigational pain therapies aimed at addressing the growing need for innovative analgesicsOctober 10, 2019 08:00 AM Eastern Daylight Time PALO ALTO, Calif.–(BUSINESS WIRE)–Neumentum Inc., a pharmaceutical company dedicated to transforming the way pain is treated, today announced it has entered into a global licensing agreement with Janssen Pharmaceutica NV […]

Read More

Neumentum Target Investment by GMH

 Q3, 2019 New Target Investment Snapshot To our investors and syndicate allies,   Global Medical Holdings has one company that we are proud to present.  The company is listed in detail below in this email and in the summary here: Neumentum, Inc.:  Neumentum is a privately held life science company focused on non-opioid alternatives to […]

Read More

Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Consent to display content from Youtube
Consent to display content from Vimeo
Google Maps
Consent to display content from Google